Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old (any gender)
- You have been diagnosed through a lab test (biopsy) with stomach cancer or cancer at the junction of the stomach and food pipe (gastroesophageal junction), at a specific intermediate-to-advanced stage (stage II or III, meaning the cancer has grown into the stomach wall or nearby areas but has not spread to distant parts of the body)
- Your doctors expect you to live for at least 3 months
- Your tumor tissue has tested positive for a protein called PD-L1 (with a score of 1 or higher)
- You have a measurable tumor that doctors believe could potentially be fully removed by surgery
- You are generally well enough to carry out light daily activities (rated 0 or 1 on a standard health scale used in cancer research)
- You have been fully informed about the trial and have signed a written agreement to take part
Who may not be able to join:
- You have taken a substance called a "taurine agent" in the month before the trial starts or plan to use it during the study (confirm with trial site)
- Your cancer tests positive for a protein called HER-2
- You have a blockage in your digestive tract, active bleeding in your stomach or gut, a hole (perforation) in your digestive tract, or difficulty swallowing
- You have serious problems with your heart, lungs, liver, kidneys, hormones, blood, or mental health that the doctors feel make it unsafe to join
- You have HIV, AIDS, an autoimmune disease, or are taking medications that suppress your immune system
- You have any other serious or complex health conditions that the trial doctors believe would make it unsafe or unsuitable for you to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xin Wang, MD, PhD, Tang-Du Hospital
Phone: 17702979587
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological complete response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.